In-Depth Research On:
Celgene Corporation (CELG)

Sign Up Now to Download a Free Research Report on CELG

Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts

Select your areas of interest / would you like to receive the newsletter?




Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader.

Celgene Corporation

Celgene shares increased 2.10 percent to close at $87.52 a share Wednesday. The stock traded between $83.98 and $87.91 on volume of 7.60 million shares traded. The company announced that its arthritis drug failed to meet its primary endpoint in a recent Phase 3 trial. Shares of Celgene are up approximately 4.0 percent year-to-date.

Going forward ... (see research report)


RESEARCH REPORT ON CELG
Download Free Report Now


Preview Pages of Actual Research Report

Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader. Research Report on    Research Report on    Research Report on    

Research Report on    Research Report on    Research Report on